The role of cytokines in the pathogenesis and treatment of herpesvirus diseases

Svirshchevskaia E.V.; Matushevskaia E.V.

doi:https://doi.org/10.17116/klinderma2018171115-120

Close metadata

Recommended articles:

Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Venereology. 2024;(6):709-712

Infectious factors in atopic dermatitis, pharmaceutical possibilities (systematic literature review). Russian Journal of Clinical Dermatology and Venereology. 2025;(1):7-15

Epidemiology of M. genitalium infection. What is known?. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):143-152

Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68

Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90

Mystery of the illness of the great painter I. Repin. By the 180th anniversary. Burdenko's Journal of Neurosurgery. 2025;(1):6-10

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59

A modern perspective on the pathogenesis of proliferative diabetic retinopathy. Russian Annals of Ophthalmology. 2025;(1):92-98

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Abstract:

Infectious diseases, including those caused by viruses, are one of the most pressing problems of the modern medicine. Herpetic infection is among the most common human viral diseases. According to the WHO, the incidence of genital herpes ranks third among the sexually transmitted infections. Increased incidence rate of herpes virus infection, new aspects of pathogenesis, and insufficient effectiveness of existing treatments necessitate the development of modern treatments, whose therapeutic effect is based on physiological regulation of pathological processes in the body.

Keywords:

herpes virus infection

herpes virus

Herpesviridae

etiology

pathogenesis

therapy

Superlymph

Authors:

Svirshchevskaia E.V.

Institut bioorganicheskoĭ khimii im. M.M. Shemiakina i Iu.A. Ovchinnikova RAN, Moskva, 117997, Rossiĭskaia Federatsiia

Matushevskaia E.V.

FGOU Institut povysheniia kvalifikatsii Federal'nogo mediko-biologicheskogo agentstva RF, Moskva

Close metadata

References:

Grinde B. Herpesviruses: latency and reactivation — viral strategies and host response. J Oral Microbiol. 2013 Oct 25;5. https://doi.org/10.3402/jom.v5i0.22766
Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006 Dec;37 Suppl 1:S39-S46.
Marchi S, Trombetta CM, Gasparini R, et al. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J Prev Med Hyg. 2017 Mar;58(1):E27-E33.
Bollaerts K, Riera-Montes M, Heininger U, et al. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data. Epidemiol Infect. 2017 Oct;145(13):2666-2677. https://doi.org/10.1017/S0950268817001546
Puhakka L, Sarvikivi E, Lappalainen M, et al. Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012. Infect Dis (Lond). 2016;48(5):406-410. https://doi.org/10.3109/23744235.2015.1123290
Varghese J, Subramanian S, Reddy MS, Shanmugam N, Balajee G, Srinivasan V, Venkataraman J, Mohamed R. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients. Indian J Med Res. 2017 Apr;145(4):558-562. https://doi.org/10.4103/ijmr.IJMR_1024_14
Myhr KM, Riise T, Barrett-Connor E, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):539-542.
Enders G, Biber M, Meyer G, Helftenbein E. Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV. Infection. 1990 Jan-Feb;18(1):12-15.
Begré L, Rohner E, Mbulaiteye SM, Egger M, Bohlius J. Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. Int J Cancer. 2016 Aug 15;139(4):776-783. https://doi.org/10.1002/ijc.30129
Krueger GR, Koch B, Leyssens N, et al. Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countries. Vox Sang. 1998;75(3):193-197.
http://www.ncbi.nlm.nih.gov/books/NBK441824/
Stanfield B, Kousoulas KG. Herpes simplex vaccines: prospects of live-attenuated HSV vaccines to combat genital and ocular infections. Curr Clin Microbiol Rep. 2015 Sep 1;2(3):125-136.
Stevenson EV, Collins-McMillen D, Kim JH, et al. HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon. Viruses. 2014 Feb 13;6(2):782-807. https://doi.org/10.3390/v6020782
Flaño E, Husain SM, Sample JT, et al. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol. 2000 Jul 15;165(2):1074-1081.
Kondo K, Yamanishi K. HHV-6A, 6B, and 7: molecular basis of latency and reactivation. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007;Chapter 47.
Coleman CB, Daud II, Ogolla SO, et al. Epstein—Barr virus type 2 infects T-cells in healthy Kenyan children. J Infect Dis. 2017 Sep 15;216(6):670-677. https://doi.org/10.1093/infdis/jix363
Hutt-Fletcher LM. The long and complicated relationship between Epstein—Barr virus and epithelial cells. J Virol. 2016 Dec 16;91(1). pii: e01677-16
Cerqueira SA, Tan M, Li S, Juillard F, et al. Latency-associated nuclear antigen E3 ubiquitin ligase activity impacts gammaherpesvirus-driven germinal center B cell proliferation. J Virol. 2016 Aug 12;90(17):7667-7683. https://doi.org/10.1128/JVI.00813-16
Shimakage M. Significant role of macrophages in human cancers associated with Epstein—Barr virus (Review). Oncol Rep. 2014 Nov;32(5):1763-1771. https://doi.org/10.3892/or.2014.3475
Korr G, Thamm M, Czogiel I, et al. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control. BMC Infect Dis. 2017 Jul 6;17(1):471. https://doi.org/10.1186/s12879-017-2527-1
Patwardhan V, Bhalla P. Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: a comparative study in Indian population from a tertiary care hospital. Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):318-321. https://doi.org/10.4103/0377-4929.188104
Gorka E, Mlynarczyk-Bonikowska B, Machura P, et al. The occurrence of herpes simplex viruses 1 and 2 in skin and mucosal lesions in patients with suspicion of genital herpes. Med Dosw Mikrobiol. 2016;68(1):57-62.
Granato PA, DeGilio MA, Wilson EM. The unexpected detection of varicella-zoster virus in genital specimens using the Lyra Direct HSV 1+2/VZV Assay. J Clin Virol. 2016 Nov;84:87-89. https://doi.org/10.1016/j.jcv.2016.10.007
James SH, Kimberlin DW. Neonatal herpes simplex virus infection. Infect Dis Clin North Am. 2015 Sep;29(3):391-400. https://doi.org/10.1016/j.idc.2015.05.001
James SH, Sheffield JS, Kimberlin DW. Mother-to-child transmission of herpes simplex virus. J Pediatric Infect Dis Soc. 2014 Sep;3 Suppl 1:S19-S23.
Skoczyński M, Krzyżanowski AR, Goździcka-Józefiak A, Kwaśniewska A. Prevalence of human papillomavirus and herpes simplex virus in amniotic fluid from pregnant women of Eastern Poland. Postepy Hig Med Dosw (Online). 2015 Dec 16;69:1349-1352.
Hensel MT, Peng T, Cheng A, et al. Selective expression of CCR10 and CXCR3 by circulating human herpes simplex virus-specific CD8 T-cells. J Virol. 2017 Sep 12;91(19);pii: e00810-17. https://doi.org/10.1128/JVI.00810-17
Goldman GS, King PG. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the antelope valley varicella active surveillance project data. Vaccine. 2013 Mar 25;31(13):1680-1694.
Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20:2500-2507.
Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015 Jul 2;1:15016. https://doi.org/10.1038/nrdp.2015.16
Ramchandani M, Kong M, Tronstein E, et al. Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults. Sex Transm Dis. 2016 Dec;43(12):756-760.
Dhankani V, Kutz JN, Schiffer JT. Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons. PLoS Comput Biol. 2014 Nov 6;10(11):e1003922. https://doi.org/10.1371/journal.pcbi.1003922 eCollection
Abad CL, Razonable RR. α Herpes virus infections among renal transplant recipients. Semin Nephrol. 2016 Sep;36(5):344-350. https://doi.org/10.1016/j.semnephrol.2016.05.011
Svensson A, Bergin AM, Löwhagen GB, et al. A 3’-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans. J Gen Virol. 2008 Sep;89(Pt 9):2262-2268. https://doi.org/10.1099/vir.0.2008/001305-0
Svensson A, Tunbäck P, Nordström I, Padyukov L, Eriksson K. Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection. J Gen Virol. 2012 Aug;93(Pt 8):1717-1724. https://doi.org/10.1099/vir.0.042572-0
Bochud PY, Magaret AS, Koelle DM, et al. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis. 2007 Aug 15;196(4):505-509.
Thapa M, Welner RS, Pelayo R, Carr DJ. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J Immunol. 2008 Jan 15;180(2):1098-1106.
Lu Y, Lin LY, Tan JG, et al. A correlation study between gene polymorphism of Th cell expressed chemokine receptor CXCR3 and its ligand levels with HCV infection prognosis. Eur Rev Med Pharmacol Sci. 2017 Mar;21(6): 1290-1295.
Kotrych D, Dziedziejko V, Safranow K, et al. CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis. Rheumatol Int. 2015 Aug;35(8):1319-1323. https://doi.org/10.1007/s00296-015-3234-0
Pineda-Tenor D, Berenguer J, Jiménez-Sousa MA, et al. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. J Clin Virol. 2014 Nov;61(3):423-429. https://doi.org/10.1016/j.jcv.2014.08.020
Patel R, Kennedy OJ, Clarke E, et al. European guidelines for the management of genital herpes. Int J STD AIDS. 2017 Jan 1:956462417727194. https://doi.org/10.1177/0956462417727194
Ershov FI, Ospel’nikova TP. The modern repertoire of antiherpetic drugs. Inf antivbrbol therapy. 2001;3:4:100-104. (In Russ.)
Mikloska Z, Cunningham AL. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J Virol. 2001;75:11821-11826.
Li J, Hu S, Zhou L, et al. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia. 2011;59:58-67.
Tumpey TM, Cheng H, Yan XT, et al. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol. 1998;63:486-492.
Kratholm SK, Iversen MB, Reinert L, et al. Interleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections. PLoS One. 2013;8:e81790.
Duerst R. Innate Immunity to Herpes Simplex Vims Type 111. Viral immunology, 2003;16(4):2003:475-490.
Barkevich OA. Anti-viral effects of the complex of natural cytokines (Superlymph) in the in vitro model of herpes virus infection. Summary of the Candidate of Medicine Thesis. Moscow. 2005. (In Russ.)
Viryasov AV. The role of cytokine complex (Superlymph) in the treatment of patients with chronic bacterial and abacterial prostatitis. Summary of the Candidate of Medicine Thesis. Moscow. 2009.(In Russ.)
Achmedov GD. Clinical efficacy of the cytokine therapy of infectious and inflammatory complications in the oral cavity surgery. Stomatologiya. 2012;3:53-55. (In Russ.)
Lokteva IA, Lasarev AI, Kaluckiy PV, Konoplya AA. Experience in administration of Superlymph in correction of the abnormal phagocyte function in gynecological patients who were treated using laparoscopic methods. Vestnik Ural’skoy meditsinskoy akademicheskoy nauki. 2006;3-1:143-145. (In Russ.)
Ushakova IG. Comparative evaluation of the effectiveness of immunotherapy for genital human papillomavirus infection in female patients. Summary of the Candidate of Medicine Thesis. Kursk. 2009. (In Russ.)
Kozyreva OV. Complex treatment of patients with recurrent genital herpes based on the systemic and local studies of cytokines. Summary of the Candidate of Medicine Thesis. Moscow. 2007. (In Russ.)
Kozyreva OV, Matushevskaya EV, Koval’chuk LV, Barkevich OA. Experience in application of Superlymph in the treatment of herpes virus infection. Klin dermatol venerol. 2007;1:16-19. (In Russ.)
Kovalchuk LV, Kozyreva OV, Matuschevskaya EV, Gankovskaya LV. Systemic and local measurement of cytokines and immunotherapy with Superlymph in patients with recurrent genital herpes. Vestn Ros State Med Univer. 2007;4:65-70. (In Russ.)
Akhmedov KhB. Clinical and laboratory characteristics and treatment of chlamydial infection associating with genital mycoplasmas. Summary of the Candidate of Medicine Thesis. Moscow. 2011. (In Russ.)
Kaschevarov DF. Pathogenetic approach to the antimicrobial and immunomodulatory therapy of the urogenital chlamydiosis. Summary of the Candidate of Medicine Thesis. Moscow. 2005. (In Russ.)
Minaya MA, Jensen T, Goll J, et al. Molecular evolution of herpes simplex virus 2 complete genomes: Comparison between primary and recurrent infections. J Virol. 2017 Sep 20. pii: JVI.00942-17. https://doi.org/10.1128/JVI.00942-17
Johnston C, Magaret A, Roychoudhury P, et al. Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 U(L) and U(S) regions from genital swabs collected from 3 continents. Virology. 2017 Oct;510:90-98. https://doi.org/10.1016/j.virol.2017.06.031